Treatments for Staple Line Leakage after Laparoscopic Sleeve Gastrectomy.
Takashi OshiroKotaro WakamatsuTaiki NabekuraYuki MoriyamaNatsumi KitaharaKengo KadoyaAyami SatoTomoaki KitaharaTasuku UritaYu SatoMakoto NagashimaMasaru TsuchiyaShinichi OkazumiPublished in: Journal of clinical medicine (2023)
The number of laparoscopic sleeve gastrectomies (LSGs) performed in patients with obesity who are eligible for bariatric and metabolic surgery is currently much lower in Japan than in other countries. Considering the large number of potential patients with obesity and type 2 diabetes and the unique Japanese national health insurance system that guarantees fair healthcare delivery, there is room to increase the number of LSGs in Japan in the near future. However, strict health insurance regulations may limit access to mandatory devices needed to treat postoperative complications, such as staple line leakage, which can cause severe morbidity and even mortality. Therefore, understanding the pathogenesis and treatment options for this complication is crucial. This article examined the current situation in Japan and its impact on staple line leakage management, including the role of endoscopic treatment in reducing reoperation. The authors suggest increasing education and collaboration between healthcare professionals to optimize management and improve patient outcomes.
Keyphrases
- health insurance
- type diabetes
- healthcare
- weight loss
- affordable care act
- insulin resistance
- metabolic syndrome
- minimally invasive
- quality improvement
- high fat diet induced
- glycemic control
- bariatric surgery
- weight gain
- roux en y gastric bypass
- robot assisted
- current status
- cardiovascular events
- cardiovascular disease
- ultrasound guided
- coronary artery disease
- coronary artery bypass
- gastric bypass
- skeletal muscle
- early onset
- social media
- risk assessment
- human health
- percutaneous coronary intervention
- body mass index
- replacement therapy